Filing Details
- Accession Number:
- 0001628280-25-034814
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-07-11 17:46:19
- Reporting Period:
- 2025-06-02
- Filing Date:
- 2025-07-11
- Accepted Time:
- 2025-07-11 17:46:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1087294 | Cumberland Pharmaceuticals Inc | CPIX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1695580 | Kenneth Krogulski | 1600 West End Ave., Suite 1300 Nashville TN 37203 | Yes | No | No | No |
Transaction Summary
| Purchased: | 935 shares | Avg. Price: $4.83 | Total Value: $4,513.10 |
| Number of Shares After Transactions: | 286,633 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-06-02 | 45 | $5.20 | 285,743 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-06-03 | 45 | $5.61 | 285,788 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-06-04 | 45 | $5.75 | 285,833 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-06-05 | 45 | $5.46 | 285,878 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-06-06 | 45 | $5.57 | 285,923 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-06-09 | 45 | $5.94 | 285,968 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-06-10 | 45 | $6.00 | 286,013 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-06-11 | 45 | $5.57 | 286,058 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-06-12 | 45 | $5.67 | 286,103 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-06-13 | 45 | $5.81 | 286,148 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-06-16 | 45 | $5.32 | 286,193 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-06-17 | 45 | $5.61 | 286,238 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-06-18 | 45 | $5.52 | 286,283 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-06-20 | 45 | $5.29 | 286,328 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-06-23 | 45 | $4.61 | 286,373 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-06-24 | 45 | $3.91 | 286,418 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-06-25 | 45 | $3.27 | 286,463 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-06-26 | 45 | $2.71 | 286,508 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-06-27 | 45 | $2.60 | 286,553 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-06-30 | 80 | $2.74 | 286,633 | No | 5 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct |
Footnotes
- The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024.
Billionaire Hedge Funds
